Anticancer drug targets: cell cycle and checkpoint control

J Clin Invest. 1999 Dec;104(12):1645-53. doi: 10.1172/JCI9054.
No abstract available

Publication types

  • Review

MeSH terms

  • Animals
  • Antineoplastic Agents / pharmacology*
  • CDC2-CDC28 Kinases*
  • Cyclin A / antagonists & inhibitors
  • Cyclin-Dependent Kinase 2
  • Cyclin-Dependent Kinase 4
  • Cyclin-Dependent Kinases / antagonists & inhibitors*
  • G1 Phase / drug effects
  • G2 Phase / drug effects
  • Humans
  • Protein-Serine-Threonine Kinases / antagonists & inhibitors
  • Proto-Oncogene Proteins*
  • S Phase / drug effects

Substances

  • Antineoplastic Agents
  • Cyclin A
  • Proto-Oncogene Proteins
  • Protein-Serine-Threonine Kinases
  • CDC2-CDC28 Kinases
  • CDK2 protein, human
  • CDK4 protein, human
  • Cyclin-Dependent Kinase 2
  • Cyclin-Dependent Kinase 4
  • Cyclin-Dependent Kinases